Ajinomoto Bio-Pharma Services
Content From Ajinomoto Bio-Pharma Services
-
AJILITY: Intelligent Drug Product Manufacturing
The AJILITY platform streamlines your drug product manufacturing program, helping you get lifesaving therapeutics to patients in less time with less complexity.White Papers / Tech Papers Released on 04.09.2021
-
Emphasizing Sustainability in Contract Manufacturing
Ajinomoto Bio-Pharma Services outlines its commitment to protecting the environment.Sponsored Content Released on 10.19.2020
-
MAY THE FLOW BE WITH YOU: CONTINUOUS FLOW MANUFACTURING OF PHARMACEUTICAL INGREDIENTS
...White Papers / Tech Papers Released on 12.19.2019
-
David Enloe at CPHI Worldwide
Interview with David Enloe, President & CEOVideos Released on 12.19.2019
-
Ajinomoto Bio-Pharma Services gives you The Power To Make
To make your vision a reality. To make your program a success. To make a positive difference in the world.Literature / Brochures Released on 08.27.2019
-
Simplifying Recombinant Protein Production: Breaking Down the Corynex Protein Expression System
The rise of biologics is having a dramatic impact on how physicians treat many serious and chronic illnesses.White Papers / Tech Papers Released on 08.27.2019
-
5 ADC Manufacturing Challenges You Need To Know
Below are five key areas where pharmaceutical manufacturers may face the biggest uphill battles.White Papers / Tech Papers Released on 08.27.2019
-
Critical Factors of Fill Finish Manufacturing For Biologics
The bulk drug substance, formulation, and sterile filtering and filling of the final drug product all require special handling procedures.White Papers / Tech Papers Released on 08.27.2019
-
Is Your Complex Formulation Process Set Up for Success?
Often, the implementation of specialized equipment and/or processes is necessary to ensure successful formulation.White Papers / Tech Papers Released on 08.27.2019
-
Preparing for Your CDMO Selection Process
Finding the CDMO that is right for your company and project can be a daunting task, particularly if this is your first time outsourcing.White Papers / Tech Papers Released on 08.27.2019
Related Content
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Resilience Acquires Ology Bioservices
Continues expansion with acquisition of biologics manufacturing company.Tim Wright, Editor, Contract Pharma 04.19.21
-
Analytical Services | Drug Delivery | Lyophilization | Process Development | Validation
Vetter Development Service
With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval.
-
Breaking News | Promotions & Moves
AGC Biologics Appoints Jun Takami GM of Chiba Site
Mr. Takami brings more than 15 years of experience in the pharmaceutical industry.Kristin Brooks 04.08.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
Work together to develop and commercialize CHI’s novel dry-powder inhaler product.Charles Sternberg, Assistant Editor 04.07.21
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement
Expands scope of Aji Bio-Pharma's service offerings to include aseptic fill finish services at its San Diego, CA facility.Kristin Brooks 03.30.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.Kristin Brooks 03.30.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
CyanVac and Exothera Enter COVID-19 Vaccine Partnership
CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.Tim Wright, Editor, Contract Pharma 03.25.21
-
Breaking News | Facilities | Industry News
Raybow Pharmaceutical Expands in U.S.
China-based CDMO will invest $15.8 million in North Carolina facility.Tim Wright, Editor, Contract Pharma 03.23.21
-
Breaking News | Drug Development | Facilities | Industry News | Parenterals
Eisai Begins Construction of New Injection/Research Building
To accommodate expanded drug discovery targets and new modalities such as antibodies, ADCs, and nucleic acid drugs.Kristin Brooks 03.22.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Lyophilization | Process Development
WuXi Biologics to Acquire CMAB Biopharma Group
Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.Kristin Brooks 03.18.21
-
Breaking News | Clinical Trial Materials | Cold Chain Management | Industry News
PCI Pharma Services Expands Cold Chain Clinical Supply Storage
Adds significant capacity and several new cold chain storage conditions, which now include temperatures from controlled room temperature to -80°C.Kristin Brooks 03.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
High Purity New England & Univercells Technologies Unveil Bioprocessing Solutions
New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.Tim Wright, Editor, Contract Pharma 03.09.21
-
cGMP Manufacture | Process Development | Scale-up/Technology Transfer
Process Intensification: Understanding the Optimal Way to Maximize Productivity
Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Facilities | Industry News
Arranta Bio Invests in New Manufacturing Facility
Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.Tim Wright, Editor, Contract Pharma 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Celonic to Boost Cell & Gene Therapy Production
Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.Tim Wright, Editor, Contract Pharma 03.05.21
-
Breaking News | Promotions & Moves
PCI Pharma Services Appoints SVP, CFO
Tom De Weerdt brings more than 20 years of experience in financial leadership roles at large, global corporations.Kristin Brooks 03.02.21
-
Breaking News | Collaborations & Alliances | Industry News
Phlow Corp. and USP Form Alliance
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.Tim Wright, Editor, Contract Pharma 03.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
BMS Expands Cell Therapy Manufacturing Capabilities
New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.Tim Wright, Editor, Contract Pharma 03.01.21
-
Breaking News | Promotions & Moves
Spark Therapeutics Appoints CTO
Cynthia Pussinen will oversee manufacturing and technical operations, including pipeline process development, preclinical and clinical manufacturing.Kristin Brooks 02.26.21
-
Manufacturing Equipment Trends
Andreas Mattern of Syntegon Technology discusses latest technologies being leveraged in manufacturing equipment today.Kristin Brooks 02.25.21
-
Bio News | Breaking News | Industry News
High Purity New England Bolsters Biopharma Solutions Services
Launches customizable cell culture bioreactor line.Tim Wright, Editor, Contract Pharma 02.25.21
-
Analytical Services | Breaking News | Facilities | Industry News | Laboratory Testing
ACG Launches ACG Laboratories
Opens a process development lab in Shirwal, India.Tim Wright, Editor, Contract Pharma 02.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Catalent Acquires Delphi Genetics
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.Tim Wright, Editor, Contract Pharma 02.23.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.Kristin Brooks 02.22.21
-
Breaking News | Industry News | Promotions & Moves
CDMO Recro Strengthens Leadership Team
Names CDMO industry thought leader Jim Miller to board and selects Ryan Lake as CFO.Tim Wright, Editor, Contract Pharma 02.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Trizell Enter Cell Therapy Deal
Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.Tim Wright, Editor, Contract Pharma 02.08.21
-
Breaking News | Industry News | Information Technology
Syntegon Validates First AI-equipped Visual Inspection System
Syringe inspection machine with AI successfully validated in a customer’s production line.Tim Wright, Editor, Contract Pharma 02.02.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lonza Launches Cryopreserved Leukopaks
Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.Kristin Brooks 01.28.21
-
Bio News | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
Ajinomoto will support fill finish for investigational COVID-19 therapeutic, lenzilumab, nearing completion of phase 3 study.Tim Wright, Editor, Contract Pharma 01.27.21
-
Breaking News | Formulation Development | Industry News | Methods Development
Adare Pharma Solutions Opens New Small-Scale Lab
Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.Kristin Brooks 01.26.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
Enter an agreement for a process development partnership.Contract Pharma Staff 01.19.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Cytiva Delivers Modular Biologics Factory to Lonza
Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Oligonucleotides
Innovate | Integrate | Customize | Accelerate
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Genezen Laboratories Receives Growth Equity Investment
Will fund the completion of the company’s lentiviral vector production facility.Contract Pharma Staff 01.05.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $40M in New Facility
State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.Contract Pharma Staff 01.05.21
-
Breaking News | cGMP Manufacture
Ajinomoto Bio-Pharma and Revance Therapeutics Partner
Sign manufacturing agreement for supply of DaxibotulinumtoxinA for injection.Contract Pharma Staff 12.22.20
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.Contract Pharma Staff 12.17.20
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
CHA Biotech Launches Global CDMO Biz
Matica Biotechnology to construct GMP facility for viral vector production in Texas.Contract Pharma Staff 12.16.20
-
Breaking News | Industry News
CPI Scales Up Manufacturing of Pyocin S5
A promising treatment for lung infection in cystic fibrosis patients developed by the University of Glasgow.Contract Pharma Staff 12.14.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Orgenesis, Cure Therapeutics Form JV
Aims to advance point-of-care development and commercialization of cell and gene therapies.Contract Pharma Staff 12.10.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Parenterals
Thermo Fisher Scientific Further Expands Global Footprint
Will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy for sterile drug product development and commercial manufacturing.Contract Pharma Staff 12.10.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
atbtherapeutics, iBio CDMO Enter Manufacturing Agreement
Will work together for the industrialization of the GMP manufacturing process of atbtherapeutics’ atbodies.Contract Pharma Staff 12.09.20
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Piramal Invests $32M to Expand Michigan Facility
Includes additional capacity in Potent and Non-Potent API development and manufacturing.Contract Pharma Staff 12.08.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact
Will advance a new generation of antibody-drug conjugates towards clinical evaluation.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio to Provide CDMO Services for ATB Therapeutics
iBio will produce ATB’s bioengineered antibody-toxin fusion proteins.Contract Pharma Staff 12.03.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
Breaking News | Industry News | Promotions & Moves
Frontida BioPharma Appoints EVP Technology
Dr. Praful Agrawala brings years of pharmaceutical product development leadership experience to the company.Contract Pharma Staff 11.20.20
-
Breaking News | Facilities | Industry News
CordenPharma Expands Peptide Development Capacity
Increases CoE for peptide development capacity to support European domestic growth.Contract Pharma Staff 11.18.20
-
Bio News | Breaking News | Industry News
Bionova Scientific Secures First Client Commitment
Its new biologics manufacturing facility is still months from completion.Contract Pharma Staff 11.18.20
-
APIs | Breaking News | Industry News
Almac Gets Grant From COVID-19 Therapeutics Accelerator
Will work to enable efficient manufacturing of remdesivir in Response to COVID-19.Contract Pharma Staff 11.18.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Syntegon Opens New OSD Customer Center
Six times more cleanroom capacity for customer projects in Waiblingen, Germany.Contract Pharma Staff 11.18.20
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Vibalogics Establishes U.S. Presence
Will open virotherapy facility in Boston and plans to invest $150 million.Contract Pharma Staff 11.16.20
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
CDMOs: Keeping up with Science & Technology
Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.Kristin Brooks, Contract Pharma 11.12.20
-
Breaking News | Industry News
TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity
Strategic partnership will leverage technical capabilities at ElevateBio for the production of TC-210 to support Phase II clinical trial.Contract Pharma Staff 11.11.20
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Parenterals
Ypsomed Collaborates with Schott and Lonza
Aims to deliver a comprehensive solution for wearable patch injectors.Contract Pharma Staff 11.10.20
-
Breaking News | Industry News | Laboratory Testing
Dalton Pharma Services Expands Capabilities
Offers extractables and leachables testing services.Contract Pharma Staff 11.10.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News | Promotions & Moves
DCAT Elects New President
Sean Diver will serve a one-year term, ending October 31, 2021.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement
Looking towards completing production in 2021.Contract Pharma Staff 10.26.20
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
Construction Starts on the Medicines Manufacturing Innovation Center
Will offer next-gen solutions in small molecule and pharmaceutical manufacturing.Contract Pharma Staff 10.26.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.10.22.20
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
APIs
Emphasizing Sustainability in Contract Manufacturing
Ajinomoto Bio-Pharma Services outlines its commitment to protecting the environment.Contract Pharma Staff
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
The Discovery Labs Appoints President and COO
Taps former Lonza Exec, Jeorg Ahlgrimm.Contract Pharma Staff 10.15.20
-
APIs
Understanding the Importance of Crystallization Processes
Crystallization is a crucial aspect of a molecule’s development and can be used to avoid unnecessary cost, risk and development delays.Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh 10.14.20
-
Capsules | Solid Dosage/Creams/Ointments
Capsule Technology Trends
A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.Julien Lamps, Product Manager, Lonza 10.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
KindredBio Expands Manufacturing Agreement with Vaxart
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.Contract Pharma Staff 10.13.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
MilliporeSigma Launches VirusExpress Platform
Scalable platform increases dose yields and reduces process development time for cell and gene therapies.10.13.20
-
Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
Cambrex Completes Edinburgh Expansion
Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.Contract Pharma Staff 10.12.20
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
Abzena Invests $60M Into cGMP Manufacturing Capacity
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.Contract Pharma Staff 10.08.20
-
Breaking News | Promotions & Moves
Almac Sciences Appoints VP
Dan Bayston has been with the company since 2003.Contract Pharma Staff 10.08.20
-
Biologics, Proteins, Vaccines | Breaking News
Kindred Bio Expands Agreement with Vaxart
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.Contract Pharma Staff 10.07.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
FDA Approves First Drug Using AJIPHASE Production Process
AJIPHASE platform is for the development and cGMP manufacture of high quality and purity commercial quantities of oligonucleotides and peptides.Contract Pharma Staff 10.07.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio Enters into Agreement with Safi Biosolutions
To develop growth factors and cytokines using the FastPharming system.Contract Pharma Staff 10.06.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
Paves the way towards getting OCU200 in the clinic by first half of 2022.Contract Pharma Staff 10.06.20
-
Breaking News | Collaborations & Alliances | Drug Development
Diamond Pharma Services Supports GenSight Biologics
Provides EU regulatory, pharmacovigilance, quality and compliance support for LUMEVOQ.Contract Pharma Staff 10.05.20
-
Breaking News | Promotions & Moves
3P Expands Management Team
Adds José Luis Bartolomé as operational excellence and continuous improvement director.Contract Pharma Staff 10.02.20
-
APIs | Breaking News | cGMP Manufacture | Industry News
BIAL, Recipharm Expand Long-Term API Supply Pact
Expanded agreement follows approval and launch of Opicapone in Japan to treat Parkinson’s.Contract Pharma Staff 10.01.20
-
Capsules | Solid Dosage/Creams/Ointments
Beyond the Boundaries
New capsule types resolve emerging formulation needs.Sven Stegemann, ACG Capsules 09.09.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Swiss American CDMO Expands in Texas
Adds new 131,760 square-foot industrial facility.Contract Pharma Staff 09.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Mapp Biopharma Partners with CDMO Avid Bioservices
For clinical development of novel human monoclonal antiviral antibody.Contract Pharma Staff 08.26.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
CDMO Ology Bioservices Gets $106.3M U.S. Army Contract
To reserve production capacity in support of Operation Warp Speed.Contract Pharma Staff 08.26.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Maravai LifeSciences Expands CDMO Capabilities at TriLink
To increase small molecule manufacturing capacity for additional scale-up of CleanCap messenger RNA capping technology for vaccine and therapeutic programs.Contract Pharma Staff 08.25.20
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals
To manufacture biopharmaceuticals at clinical development stage.Contract Pharma Staff 08.20.20
-
Breaking News | Industry News
Swiss American CDMO Appears In 2020 Inc. 5000 List
Named one of the fastest-growing private companies in America.Contract Pharma Staff 08.18.20
-
Breaking News | Facilities | Industry News | R&D
CDMO Sai Life Sciences Opens New Facility
State-of-the-art research and technology center is located in Hyderabad, India and completes first phase in $150 million investment.Contract Pharma Staff 08.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Beroni Signs Agreement with CDMO Genscript Biotech
To conduct further study to develop nanobody-based medical solution for COVID-19.Contract Pharma Staff 08.12.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sekisui Diagnostics Invests in Biopharma CDMO Capacity
Investing £14.4 million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at its site in Maidstone, Kent.Contract Pharma Staff 08.04.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Altimmune and CDMO Vigene Enter COVID-19 Vax Pact
Ink manufacturing agreement for AdCOVID single dose intranasal vaccine candidate.Contract Pharma Staff 08.03.20
-
Breaking News | cGMP Manufacture
Sekisui Invests $18.93 Million in Biopharma CDMO Business
Expands cGMP microbial capacity in Maidstone, Kent site.Contract Pharma Staff 07.31.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
GenScript Expands CDMO Capabilities
Launches CDMO segment "GenScript ProBio" dedicated to providing services from discovery to commercialization.Contract Pharma Staff 07.23.20
-
How One CDMO Used an Innovative Technology to Overcome Viral Vaccine Production Challenges
Join us for a webinar on 8/18 to learn how Ology Biosciences is leveraging innovative technologies and expertise to bring vaccine production to the next level.07.20.20
-
Breaking News | Industry News
Ajinomoto Bio-Pharma Launches Ajility
A fast track platform for drug product manufacturing.Contract Pharma Staff 06.30.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development
SwiftScale Manufactures COVID-19 Antibody Candidate
Uses rapid biologics manufacturing technology to accelerate development of treatments.Contract Pharma Staff 06.09.20
-
Drug Delivery
Not Your Father’s Oral Thin Film
A look at how oral film drug delivery is evolving.Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20
-
A Guide to Vaccine Development from Lubrizol Life Science
The current COVID-19 pandemic emphasizes the need for safe and effective vaccines against new pathogens.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
WuXi Launches CAR-T Cell Therapy Platform
Will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patientsContract Pharma Staff 05.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Vibalogics to Manufacture Clinical Material for Janssen
CDMO to provide additional clinical trial material for COVID-19 vaccine candidateContract Pharma Staff 05.14.20
-
APIs | Breaking News | cGMP Manufacture | Excipients | Industry News
Evonik Commissions Advanced Biomaterials Production Facility
Expands range of CMO services for the scale-up and commercial manufacturing of customer’s own excipients in Birmingham, AL.Contract Pharma Staff 05.13.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
HJB, Mabspace Ink Development and Manufacturing Agreement
Program aims to bring more efficacious treatment options to cancer patientsContract Pharma Staff 05.12.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Themis Collaborates with ABL Europe
ABL will manufacture Themis’ SARS-CoV-2 vaccine candidate in FranceContract Pharma Staff 05.12.20
-
-
Breaking News | Collaborations & Alliances | Industry News
Sterling Begins HCQ Production in UK
Partners with Accord Healthcare for the manufacture of potential COVID-19 treatmentContract Pharma Staff 05.11.20
-
Breaking News | Industry News | Promotions & Moves
Alcami Makes Senior Leadership Appointments
Sally Langa to lead biz dev efforts; Kimberly McClintock returns to head-up marketingContract Pharma Staff 05.08.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
Aji Bio-Pharma, CytoDyn Enter COVID-19 Mfg. Pact
Aji Bio-Pharma provides drug product aseptic fill finish services for CytoDyn's Leronlimab, currently being used in clinical trials for COVID-19 patientsContract Pharma Staff 05.05.20
-
Bio News | Biologics, Proteins, Vaccines | Drug Development | Drug Discovery
Trio Pharma, Aji Bio-Pharma Enter ADC Alliance
To evaluate AJICAP, Aji Bio's site-specific conjugation technology for the development of TRIObody Drug ConjugatesContract Pharma Staff 04.30.20
-
Breaking News | Drug Development | Industry News
AGC Biologics, AdaptVac Partner to Develop COVID-19 Vaccine
Will leverage AdaptVac's Virus-Like Particle (VLP) technology that could provide a solution to protect against new SARS-CoV-2 infections.Contract Pharma Staff 04.27.20
-
Vetter’s high performance is again recognized at the 2020 CMO Leadership Awards
A win in all six core categories reaffirms Vetter as a trusted solution provider
-
-
David Enloe at CPHI Worldwide
Interview with David Enloe, President & CEO
-
Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Formulation Development
Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma
David Enloe of Ajinomoto Bio-Pharma Services shares his perspective on market changes over the years and the evolution of more integrated outsourcingKristin Brooks, Contract Pharma 11.11.19
-
Analytical Services | Industry News | QA/QC
Recipharm Launches Recipharm Analytical Solutions
Stand-alone service offers analytical services including method development, method validation, and stability program design and implementation11.04.19
-
-
Breaking News | cGMP Manufacture | Industry News
ANI Launches New CDMO Brand ANI Global Source
Following the integration of WellSpring, the specialty CDMO will support late stage development and commercial manufacture of pharmaceutical products.10.29.19
-
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Eurofins Discovery and Escient Form Collaboration
Eurofins to provide assay development and drug discovery services.10.28.19
-
Contract Pharma’s 20th Anniversary Retrospective
A look back a the pharma/biopharma industry and the future of outsourcing.Kristin Brooks, Managing Editor, Contract Pharma 10.15.19
-
-
APIs | cGMP Manufacture | Industry News
Aji Bio-Pharma Buys Out India Joint Venture
JV, formed in 2011, provides small molecule intermediates and API manufacturing to the pharmaceutical industry08.29.19
-
Ajinomoto Bio-Pharma Services gives you The Power To Make
To make your vision a reality. To make your program a success. To make a positive difference in the world.
-
Bio News | Breaking News | Industry News | Promotions & Moves
Avid Names Richard Hancock Interim President & CEO
Industry veteran with over 30 years of operational and executive experience succeeds Roger Lias05.20.19
-
APIs | Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
GeneDesign Joins Ajinomoto Bio-Pharma Services
Opens oligonucleotide API development center04.09.19
-
Bio News | Breaking News | Promotions & Moves
Ajinomoto Appoints VP of Sales & Marketing
Jean-Baptiste Agnus joins Ajinomoto Bio-Pharma Services from Novasep04.03.19
-
APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
Ajinomoto Bio-Pharma Services Expands
Invests more than $100 million to further expand offerings and capabilities in both the U.S. and Belgium03.12.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Ajinomoto, XL-protein Forge Strategic Alliance
Ajinomoto will apply its Corynex expression system with XL-protein's PASylation technology to develop a series of therapeutic compounds12.18.18
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D | Reader Showcase
Aji Bio-Pharma Introduces New ADC Mfg. Technology
AJICAP technology lets developers of ADCs to better control the location of payload conjugation to an antibody11.28.18
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances
Ajinomoto Bio-Pharma Services, Precision Nanosystems in Mfg. Pact
Will leverage PNI's NanoAssemblr to support clients into clinical development through to commercialization of nanomedicines10.23.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Ajinomoto Althea and OmniChem Integrate
Businesses and operations will integrate as a unified CDMO, and will operate as Ajinomoto Bio-Pharma Services10.02.18
-
cGMP Manufacture | Industry News | Promotions & Moves
Ajinomoto Althea Makes Key VP Hires
Bert Barbosa to serve as VP of Drug Product Manufacturing and Darwin Richardson to serve as VP of Compliance05.31.18
-
Industry News
Ajinomoto Althea CEO Recognized for Achievements
Recognized for leading significant growth and fostering several technical and organizational development initiatives07.06.17
-
APIs | Breaking News | Industry News
Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Mfg.
Building out this continuous flow platform is supported by the multi-year grant awards from the Belgian government04.13.17
-
Aseptic Processing | Breaking News | Fill/Finish | Parenterals | Promotions & Moves | Regulatory Affairs
Ajinomoto Althea Bolsters Regulatory Affairs Team
Names Lori McDonald vice president of compliance04.06.17
-
Clinical Trial Materials | Drug Development | Industry News | Scale-up/Technology Transfer
Biologic Candidate Using Ajinomoto CORYNEX System Enters Trials
Althea successfully scales up and produces GMP material for Phase I trial using CORYNEX system10.04.16
-
APIs | Inspections
The Western API Industry
Temporary reprieve or lasting recovery?Dr. Enrico T. Polastro, Arthur D. Little 01.28.16
-
Collaborations & Alliances
Filament BioSolutions, Ajinomoto Form Partnership
Focus will be on developing a portfolio of evidence-based medical foods01.11.16
-
Breaking News | Industry News
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
